Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10170626 | 0.87 | PAOX (0.39) | ALDH1A1PAOXLMNASLC15A2CHRM1 | |
| SCHEMBL10170326 | 0.82 | PHF8 (0.40) | KMT2AMEN1CHRM1 | |
| SCHEMBL11912053 | 0.80 | ALDH1A1 (0.53) | ALDH1A1KMT2AMEN1PAOXLMNA | |
| SCHEMBL12602742 | 0.78 | ALDH1A1 (0.50) | ALDH1A1KMT2AMEN1PAOXLMNA | |
| SCHEMBL10170636 | 0.76 | ALDH1A1 (0.30) | ALDH1A1GAA | |
| SCHEMBL10170629 | 0.74 | PAOX (0.41) | ALDH1A1KMT2AMEN1PAOXLMNA | |
| SCHEMBL10170317 | 0.74 | KDM4C (0.43) | ALDH1A1KMT2AMEN1LMNA | |
| SCHEMBL14085585 | 0.73 | — | — | |
| SCHEMBL18650125 | 0.73 | ALDH1A1 (0.46) | ALDH1A1LMNASLC15A2CHRM1 | |
| SCHEMBL10170630 | 0.72 | ALDH1A1 (0.35) | ALDH1A1LMNASLC15A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105073940-A | Transparent flexible hard coating film and method for producing same | KOREA ADVANCED INST SCI & TECH | 2015-11-18 | — | — | CN | disclosed |
| CN-104710934-A | Hard coating film using composition including epoxysilicone resin and method for preparing the same | KOREA ADVANCED INST SCI & TECH | 2015-06-17 | — | — | CN | disclosed |
| US-20120035226-A1 | OXADIAZOLE DERIVATIVES | MERCK SERONO SA (CH) | 2012-02-09 | — | — | US | disclosed |
| US-20120022109-A1 | OXADIAZOLE DERIVATIVES | MERCK SERONO SA (CH) | 2012-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120022109-A1 | OXADIAZOLE DERIVATIVES | OXA1L, HLA-DRB1, SSB | ALDH1A1 510/4885KMT2A 3914/4885MEN1 1228/4885 |
| US-20120035226-A1 | OXADIAZOLE DERIVATIVES | OXA1L, HLA-DRB1, SSB | ALDH1A1 510/4885KMT2A 3914/4885MEN1 1228/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.